Literature DB >> 23855377

Systemic involvement of acute generalized exanthematous pustulosis: a retrospective study on 58 patients.

C Hotz1, L Valeyrie-Allanore, C Haddad, S Bouvresse, N Ortonne, T A Duong, S Ingen-Housz-Oro, J C Roujeau, P Wolkenstein, O Chosidow.   

Abstract

BACKGROUND: Acute generalized exanthematous pustulosis (AGEP) is a severe cutaneous adverse reaction characterized by rash with sterile pustules, high fever and elevated circulating neutrophil counts.
OBJECTIVES: To investigate the frequency and clinical features of AGEP systemic involvement.
METHODS: This retrospective study included all patients hospitalized in our department between 2000 and 2010 with a discharge diagnosis of AGEP. Patients had to fulfil the following criteria: (i) a specific EuroSCAR score > 4 and (ii) biological and radiological work-up available.
RESULTS: Among the 58 patients enrolled, 10 had at least one systemic involvement: hepatic function test results were abnormal for seven; six had renal insufficiency; two developed acute respiratory distress, with one patient's bronchoalveolar lavage fluid containing many neutrophils but no microorganisms; one was agranulocytotic. Mean peripheral neutrophil counts and mean C-reactive protein levels were elevated significantly in patients with systemic involvement. Amoxicillin rechallenge and hospitalization duration were associated with systemic involvement. AGEP systemic involvement was observed in 17% of cases studied, including liver, kidney, bone-marrow and lung involvement. Outcomes were favourable after drug withdrawal, and symptomatic and topical steroid treatments.
CONCLUSIONS: The neutrophil count-systemic involvement association may suggest a role for neutrophils in AGEP systemic involvement. Physicians should be aware of the possibility of systemic involvement in AGEP and should actively look for signs of extracutaneous reactions.
© 2013 British Association of Dermatologists.

Entities:  

Mesh:

Year:  2013        PMID: 23855377     DOI: 10.1111/bjd.12502

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  26 in total

Review 1.  The 9th International Congress on Cutaneous Adverse Drug Reactions at the 23rd World Congress of Dermatology in Vancouver, 2015.

Authors:  Roni P Dodiuk-Gad; Cristina Olteanu; Wen-Hung Chung; Neil H Shear
Journal:  Drug Saf       Date:  2016-03       Impact factor: 5.606

Review 2.  Drug reactions with eosinophilia and systemic symptoms.

Authors:  B Scrace; A Fityan; C Bigham
Journal:  BJA Educ       Date:  2020-01-08

3.  Acute generalized exanthematous pustulosis reported due to loxosceles envenomation may be secondary to azithromycin therapy.

Authors:  Roxanne M Rajaii; Katie S Payne; Joseph M Malters; William V Stoecker
Journal:  Mo Med       Date:  2014 May-Jun

Review 4.  Fever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy.

Authors:  Rebecca Pavlos; Simon Mallal; David Ostrov; Yuri Pompeu; Elizabeth Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2014 Jan-Feb

5.  Cutaneous vasculitis overlap with acute generalised exanthematous pustulosis (AGEP).

Authors:  Aizuri Murad; Annette Murphy
Journal:  BMJ Case Rep       Date:  2014-11-17

Review 6.  Severe Delayed Cutaneous and Systemic Reactions to Drugs: A Global Perspective on the Science and Art of Current Practice.

Authors:  Jonathan Grant Peter; Rannakoe Lehloenya; Sipho Dlamini; Kimberly Risma; Katie D White; Katherine C Konvinse; Elizabeth J Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2017 May - Jun

Review 7.  Cutaneous Drug Reactions in the Elderly.

Authors:  James W S Young; Neil H Shear
Journal:  Drugs Aging       Date:  2017-09       Impact factor: 4.271

8.  Hydroxychloroquine-induced acute generalized exanthematous pustulosis with positive patch-testing.

Authors:  Ons Charfi; Sarrah Kastalli; Rym Sahnoun; Ghozlane Lakhoua
Journal:  Indian J Pharmacol       Date:  2015 Nov-Dec       Impact factor: 1.200

9.  A case of acute generalized exanthematous pustulosis associated with polyarteritis nodosa, responding to systemic steroids.

Authors:  Ayham M Alkhachroum; Nayef Kazzaz
Journal:  J Community Hosp Intern Med Perspect       Date:  2015-04-01

Review 10.  Current Perspectives on Severe Drug Eruption.

Authors:  Jingzhan Zhang; Zixian Lei; Chen Xu; Juan Zhao; Xiaojing Kang
Journal:  Clin Rev Allergy Immunol       Date:  2021-07-17       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.